197 related articles for article (PubMed ID: 16444997)
1. Evaluation of [11C]SA5845 and [11C]SA4503 for imaging of sigma receptors in tumors by animal PET.
Kawamura K; Kubota K; Kobayashi T; Elsinga PH; Ono M; Maeda M; Ishiwata K
Ann Nucl Med; 2005 Dec; 19(8):701-9. PubMed ID: 16444997
[TBL] [Abstract][Full Text] [Related]
2. Tumor imaging with 2 sigma-receptor ligands, 18F-FE-SA5845 and 11C-SA4503: a feasibility study.
van Waarde A; Buursma AR; Hospers GA; Kawamura K; Kobayashi T; Ishii K; Oda K; Ishiwata K; Vaalburg W; Elsinga PH
J Nucl Med; 2004 Nov; 45(11):1939-45. PubMed ID: 15534066
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of (+)-p-[11C]methylvesamicol for mapping sigma1 receptors: a comparison with [11C]SA4503.
Ishiwata K; Kawamura K; Yajima K; QingGeLeTu ; Mori H; Shiba K
Nucl Med Biol; 2006 May; 33(4):543-8. PubMed ID: 16720247
[TBL] [Abstract][Full Text] [Related]
4. Preclinical evaluation of [11C]SA4503: radiation dosimetry, in vivo selectivity and PET imaging of sigma1 receptors in the cat brain.
Kawamura K; Ishiwata K; Shimada Y; Kimura Y; Kobayashi T; Matsuno K; Homma Y; Senda M
Ann Nucl Med; 2000 Aug; 14(4):285-92. PubMed ID: 11023029
[TBL] [Abstract][Full Text] [Related]
5. Comparison of sigma-ligands and metabolic PET tracers for differentiating tumor from inflammation.
van Waarde A; Jager PL; Ishiwata K; Dierckx RA; Elsinga PH
J Nucl Med; 2006 Jan; 47(1):150-4. PubMed ID: 16391199
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and evaluation of fluorine-18-labeled SA4503 as a selective sigma1 receptor ligand for positron emission tomography.
Kawamura K; Tsukada H; Shiba K; Tsuji C; Harada N; Kimura Y; Ishiwata K
Nucl Med Biol; 2007 Jul; 34(5):571-7. PubMed ID: 17591557
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of [18F]fluorinated sigma receptor ligands in the conscious monkey brain.
Elsinga PH; Tsukada H; Harada N; Kakiuchi T; Kawamura K; Vaalburg W; Kimura Y; Kobayashi T; Ishiwata K
Synapse; 2004 Apr; 52(1):29-37. PubMed ID: 14755630
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and evaluation of [18F]fluoroethyl SA4503 as a PET ligand for the sigma receptor.
Elsinga PH; Kawamura K; Kobayashi T; Tsukada H; Senda M; Vaalburg W; Ishiwata K
Synapse; 2002 Mar; 43(4):259-67. PubMed ID: 11835521
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and in vivo evaluation of [11C]SA6298 as a PET sigma1 receptor ligand.
Kawamura K; Ishiwata K; Tajima H; Ishii S; Shimada Y; Matsuno K; Homma Y; Senda M
Nucl Med Biol; 1999 Nov; 26(8):915-22. PubMed ID: 10708305
[TBL] [Abstract][Full Text] [Related]
10. [11C]Raclopride binding was reduced in vivo by sigma(1) receptor ligand SA4503 in the mouse brain, while [11C]SA4503 binding was not by raclopride.
Ishiwata K; Kobayashi T; Kawamura K; Matsuno K; Senda M
Nucl Med Biol; 2001 Oct; 28(7):787-92. PubMed ID: 11578899
[TBL] [Abstract][Full Text] [Related]
11. Age-related changes of the binding of [3h]SA4503 to sigma1 receptors in the rat brain.
Ishiwata K; Kobayashi T; Kawamura K; Matsuno K
Ann Nucl Med; 2003 Feb; 17(1):73-7. PubMed ID: 12691135
[TBL] [Abstract][Full Text] [Related]
12. Rapid reduction of sigma1-receptor binding and 18F-FDG uptake in rat gliomas after in vivo treatment with doxorubicin.
van Waarde A; Shiba K; de Jong JR; Ishiwata K; Dierckx RA; Elsinga PH
J Nucl Med; 2007 Aug; 48(8):1320-6. PubMed ID: 17631546
[TBL] [Abstract][Full Text] [Related]
13. Small-animal PET with a σ-ligand, 11C-SA4503, detects spontaneous pituitary tumors in aged rats.
Ramakrishnan NK; Rybczynska AA; Visser AK; Marosi K; Nyakas CJ; Kwizera C; Sijbesma JW; Elsinga PH; Ishiwata K; Pruim J; Dierckx RA; van Waarde A
J Nucl Med; 2013 Aug; 54(8):1377-83. PubMed ID: 23785170
[TBL] [Abstract][Full Text] [Related]
14. In vivo evaluation of [(11)C]SA4503 as a PET ligand for mapping CNS sigma(1) receptors.
Kawamura K; Ishiwata K; Tajima H; Ishii S; Matsuno K; Homma Y; Senda M
Nucl Med Biol; 2000 Apr; 27(3):255-61. PubMed ID: 10832082
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and evaluation of vesamicol analog (-)-O-[11C]methylvesamicol as a PET ligand for vesicular acetylcholine transporter.
Kawamura K; Shiba K; Tsukada H; Nishiyama S; Mori H; Ishiwata K
Ann Nucl Med; 2006 Jul; 20(6):417-24. PubMed ID: 16922470
[TBL] [Abstract][Full Text] [Related]
16. Early response of sigma-receptor ligands and metabolic PET tracers to 3 forms of chemotherapy: an in vitro study in glioma cells.
van Waarde A; Been LB; Ishiwata K; Dierckx RA; Elsinga PH
J Nucl Med; 2006 Sep; 47(9):1538-45. PubMed ID: 16954564
[TBL] [Abstract][Full Text] [Related]
17. Design and Investigation of a [
Yang D; Comeau A; Bowen WD; Mach RH; Ross BD; Hong H; Van Dort ME
Mol Pharm; 2017 Mar; 14(3):770-780. PubMed ID: 28135101
[TBL] [Abstract][Full Text] [Related]
18. Imaging of sigma1 receptors in the human brain using PET and [11C]SA4503.
Toyohara J; Sakata M; Ishiwata K
Cent Nerv Syst Agents Med Chem; 2009 Sep; 9(3):190-6. PubMed ID: 20021353
[TBL] [Abstract][Full Text] [Related]
19. Mapping of human cerebral sigma1 receptors using positron emission tomography and [11C]SA4503.
Sakata M; Kimura Y; Naganawa M; Oda K; Ishii K; Chihara K; Ishiwata K
Neuroimage; 2007 Mar; 35(1):1-8. PubMed ID: 17240168
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
